ReviewBiomaterials2026

Proteolysis-targeting chimera (PROTAC) nanomedicines toward cancer treatment: From synthesis to therapeutic delivery.

Yilin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.